Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China · Delayed Price · Currency is CNY 16.85
-0.23 (-1.35%)
At close: Jan 16, 2026
SHA:600161 Market Cap
SHA:600161 has a market cap or net worth of 33.32 billion as of January 16, 2026. Its market cap has decreased by -18.64% in one year.
Market Cap
33.32B
Enterprise Value
35.14B
Revenue
6.42B
Ranking
n/a
PE Ratio
25.55
Stock Price
16.85
Market Cap Chart
Since March 8, 2000, SHA:600161's market cap has increased from 3.95B to 33.32B, an increase of 744.04%. That is a compound annual growth rate of 8.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 33.32B | 3.12% |
| Dec 31, 2025 | 32.31B | -20.29% |
| Dec 31, 2024 | 40.54B | -20.49% |
| Dec 29, 2023 | 50.98B | 30.38% |
| Dec 30, 2022 | 39.10B | -1.67% |
| Dec 31, 2021 | 39.77B | -23.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 423.21B |
| WuXi AppTec | 307.86B |
| Shenzhen Mindray Bio-Medical Electronics | 251.26B |
| Sichuan Biokin Pharmaceutical | 138.31B |
| Shanghai United Imaging Healthcare | 118.81B |
| Aier Eye Hospital Group | 108.48B |
| Zhangzhou Pientzehuang Pharmaceutical., | 102.24B |
| Yunnan Baiyao Group Co.,Ltd | 100.67B |